LASA Medication Error Detection Using Dosage Context
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmacy systems fail to adequately detect and prevent look-alike sound-alike (LASA) medication errors, leading to false positive warnings and inefficiencies, as they rely solely on whether a drug name is included in a LASA drug pair, without considering dosage or clinical context.
Innovation Solution
A system and method that identify submitted drug products associated with LASA drug pairs and assess whether the daily dosage meets statistically derived typical or absolute dosing criteria, generating messages and edit actions based on clinical significance and prescription type to alert pharmacists of potential errors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alert systems generate a warning message any time a drug product having a drug name that is included in a LASA drug pair is detected, then medication error detection coverage is improved, but false positive rate increases and pharmacist workload increases
Solution Approach 1:
The system changes the parameters used for error detection from simple drug name matching to a multi-parameter assessment including dosage amount, dosage frequency, patient demographics, and clinical context. This allows the system to distinguish between legitimate prescriptions and actual errors, reducing false positives while maintaining detection coverage.
Solution Approach 2:
The system implements dynamic alert generation that adapts to specific prescription contexts. Rather than static name-based warnings, the system dynamically evaluates each prescription against multiple criteria and generates context-appropriate alerts only when genuine errors are detected, adjusting the sensitivity and type of messaging based on the specific situation.
2Device complexity
If existing systems rely solely on whether a drug name is included in a LASA drug pair, then system complexity is reduced, but detection accuracy deteriorates
Solution Approach 1:
The system segments the error detection process into multiple independent evaluation components: drug name similarity assessment, dosage amount validation, dosage frequency checking, patient demographic analysis, and clinical context evaluation. Each segment handles a specific aspect of error detection, allowing the system to maintain moderate complexity while achieving high detection accuracy through the combination of specialized sub-functions.
3Reliability
If high volume of warning messages is generated, then sensitivity to potential errors is improved, but pharmacist efficiency deteriorates due to message burden
Solution Approach 1:
The system applies partial action by generating alerts selectively rather than universally. It performs comprehensive error checking on all prescriptions but generates actionable warning messages only when specific error conditions are met, avoiding excessive messaging. This maintains high sensitivity for detecting potential errors while ensuring that pharmacists receive only the most relevant alerts, preserving efficiency.
Data Source
AI summary
Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. If it is determined that the prescription should be rejected based on typical dosing criteria or absolute dosing criteria, a reject message may be built for presentation to the pharmacist.